I would assume that the TGA rarely approves clinical trials within Australia without passing stringent requirements, so Imugene has been able to cross the line and broaden its clinical trials outside of US
Ann: Imugene Opens First Australian Site for azer-cel Trial, page-7
Add to My Watchlist
What is My Watchlist?